Post
of 161,087
As Evil pointed out in his reply there's a ton of stuff that they could have updated us on. I did go back through old press releases and see they did skip the newsletter in Q2 last year around the time of ESMO-mania so forgoing the formal quarterly notifications is not unprecedented.
We were told EAP was supposedly starting up this month but you can see that the EAP page remains unpopulated. Note: go here and click on Cytodyn link to EA page .
While they can't reveal exact trial results they can certainly spin us the human story around it (enrollees and dosing splits 350/700, observations, etc.). They can also tell us what's happened to LL #6, who has been on LL since April and an ICI since August IIRC.
I guess we wait until after the embargos end in mid-April, but it won't stop me from Pavlovian salivations around 0830 each weekday.
Adding: would it kill them to update the clinical trials page??? Nothing new since 10/2/25.
We were told EAP was supposedly starting up this month but you can see that the EAP page remains unpopulated. Note: go here and click on Cytodyn link to EA page .
While they can't reveal exact trial results they can certainly spin us the human story around it (enrollees and dosing splits 350/700, observations, etc.). They can also tell us what's happened to LL #6, who has been on LL since April and an ICI since August IIRC.
I guess we wait until after the embargos end in mid-April, but it won't stop me from Pavlovian salivations around 0830 each weekday.
Adding: would it kill them to update the clinical trials page??? Nothing new since 10/2/25.
Quote:I thought we would see a shareholders letter by today. It is going to be a long few days until next week.
11